Aeglea BioTherapeutics

0 followers

Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.

Industries

Employees

51-200

Links


Org chart

Russell J. Cox
Chief Executive Officer, Epirium Bio
Collapse
Cortney Caudill
Chief Product Officer
Cecilia Castillo
Executive Assistant
Gillian Bubb
Senior Director Clinical Science, Clinical Development. Rare Genetic Disease

Board & advisors

Peter Harwin
Director